Really fantastic article by Karen Spink, Head of Medicines at Innovate UK, on the current landscape for childhood cancer therapeutics. Not to mention the fact that she says really very complementary things about the report we wrote together... 👀
Dr Karen Spink, Head of Medicines at Innovate UK, has written an article about the importance of putting the child first when creating future life-changing cancer therapies. She outlines some of the reasons why relatively little research and investment are focused on this field of medicine, as well as some of the reasons to be optimistic about the future. The article references the work carried out with venture creation specialists Deep Science Ventures to explore the landscape of therapeutic approaches in paediatric oncology. The resulting white paper Revolutionising Paediatric Cancer Treatment, launched in February 2024, highlights opportunities with significant potential to attract the investment needed to deliver transformative therapies for children with cancer. Read the article here - https://ow.ly/pfnT50TCif6 #ChildhoodCancer #Innovation #PaediatricOncology #CancerImmunotherapy #CancerResearch #CancerVaccine #ImmunoOncology #CancerTherapeutics